Bad News Flash: Scientists Did Not Cure Autism, Cancer Or Alzheimer's
By Steven Salzberg,
Forbes
| 03. 07. 2016
This week I’m calling out some recent headlines about medical “breakthroughs” that were wildly misleading. Even when the science itself is good, bad reporting raises false hopes and eventually undermines the public’s confidence. At some point, people will just no longer believe the headlines claiming that someone has once again cured cancer.
My first example of bad news is from a couple of weeks ago. I was struck by a headline that showed up in one of my news feeds that read:
Neuroscientists reverse autism symptoms
Wow, I thought. This would be a real breakthrough if it were true. I traced the headline back to the MIT press office, where I then saw the subheading: “turning on a gene later in life can restore typical behavior in mice.” Uh oh: Extrapolating any treatment from mice to humans is fraught with problems, and studying a complex behavioral disorder like autism is even more difficult.
The HuffPo fell for it, though. Their headline read, “Some Autism Symptoms May Be Reversed By Gene Editing, Scientists Suggest.” So did the Daily Mail, which...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...